LookCloser.aipublic supplement evidence
Exact product checked · GTIN 00850061389480Toniiq · checked Aug 2, 2026 · on sale since Aug 29, 2024🇺🇸 USPTO wordmark owner · Toniiq LLC · MICHIGAN, USA; WYOMING, USAPackage says distributed by: TONIIQ LLC · 2045 W. GRAND AVE STE B, #70517 CHICAGO, IL 60612-1577 US
Quick read · Toniiq

Toniiq NMNH Supplement – Clinically Studied…

Checked against public sources on August 2, 2026 · LookCloser does not sell or recommend supplements.

60capsules · 30 servings

Does the marketing hold up?

Testing claimed — documentation not found. The observed listing claims third-party testing without naming a lab or certifier. No product-bound report is saved, so the claim cannot be verified as stated. …

Is the dose real?Can’t check — no panel filed
What a serving costs$1.83per serving, at the checked price
Is it tested?Claimed — no lab or certificate found
Who’s behind it?🇺🇸Toniiq LLClimited liability company · MICHIGAN, USA; WYOMING, USA
Is it the real thing?Barcode matches outside records
Trouble on record?No recalls found

“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.

2◖ partly confirmed1△ support not found1? couldn’t verifyno contradictions · no recalls
Marketing claims, checked

The checks, one by one

1 promise needs a closer look.

Partly confirmed2

“higher level of purity ensures maximum effectiveness and bioavailability, providing the most potent support for your NAD+”

Published research exists for ingredients in this formula. Whether this product’s doses match those studies could not be confirmed.

Evidence →
“products are produced in a GMP-certified, state-of-the-art manufacturing facility right here in the”

“GMP-certified” describes factory processes, not what is in the bottle. The claim does not name a certifier or public register that a shopper can check.

Evidence →

Ingredient research can support context, but it is not a trial of this exact product.

Claimed without support found1

“Toniiq NMNH Supplement – Clinically Studied”

We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.

Evidence →

?Couldn’t verify independently1

“Third-Party Tested Purity: Our NMNH supplement boasts an impressive 95% purity level, verified by third-party”

No named laboratory or lot-specific certificate was found for this exact product. No exact brand product page was available for a document check. Under NSF/ANSI 173, NSF lists Toniiq, LLC products, including Resveratrol, but not this exact SKU. IFOS, USP, and Informed-Sport were not checked in this record. This is a public-evidence limit, not a finding that testing did not occur.

Evidence →

We looked and found no public proof. That does not count against the product.

Quick read · 2 useful findings

What is worth knowing.

Headlines first. Open evidence only when you want the source trail.

CheckedWho is behind it?

The barcode identity checks out · 850061389480.

The barcode matches, so we are checking the right product rather than a look-alike.

Evidence and sources

Open Food Facts resolves 850061389480 to "NMNH" (Toniiq) — consistent with this listing.

Locked evidence record →Open the full source-linked finding
CheckedCan you trust the review pattern?

Reviews rose from 22 to 42 between July 8, 2025 and July 19, 2026 — no sudden jump.

A count that moves steadily is ordinary. A sudden burst is what deserves a closer look.

Evidence and sources

Written reviews rose from 22 to 42 between July 8, 2025 and July 19, 2026. The largest rise inside any single 30-day window was about 3, so the count moved in steps rather than in one burst.

Locked evidence record →Open the full source-linked finding
What remains open 2
  • No FDA recall matched this brand in the current search.
  • We have not found a public label filing for this exact product.

These are evidence gaps, not strikes against the product.

Who owns the brand wordmark?
🇺🇸
Toniiq LLCLimited Liability Company · exact supplement-class mark for TONIIQ
Registration5511231
Registered2018-07-10
AssignmentsYes

Filed address
1608 S. Ashland Ave., Chicago, ILLINOIS 70517, UNITED STATES

USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗

Research behind the findings

Dose and research context

We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.

Where it sells

Price check for this exact product

Amazon

Exact UPC/GTIN match
$54.97

$1.83 per labeled serving

matching UPC/GTIN · checked Aug 2, 2026

View on Amazon ↗

iHerb

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search iHerb ↗

Target

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search Target ↗

Walmart

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search Walmart ↗

Only one exact price was available at build time; prices change by date, seller, and promotion.

Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.

Want to inspect the evidence?

The full report shows every source, the exact unresolved question, and the documentation that would settle it.

Read / share full evidence →

Record built August 02, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.